首页> 外文OA文献 >Formulation development of a carrageenan based delivery system for buccal drug delivery using ibuprofen as a model drug
【2h】

Formulation development of a carrageenan based delivery system for buccal drug delivery using ibuprofen as a model drug

机译:使用布洛芬作为模型药物的基于角叉菜胶的口腔给药系统的配方开发

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Solvent cast films are used as oral strips with potential to adhere to the mucosal surface, hydrate and deliver drugsudacross the buccal membrane. The objective of this study was the formulation development of bioadhesive films withudoptimum drug loading for buccal delivery. Films prepared from κ-carrageenan, poloxamer and polyethylene glycol orudglycerol, were loaded with ibuprofen as a model water insoluble drug. The films were characterized using textureudanalysis (TA), hot stage microscopy (HSM), differential scanning calorimetry (DSC), thermogravimetric analysis (TGA),udscanning electron microscopy (SEM), x-ray powder diffraction (XRPD), high performance liquid chromatographyud(HPLC) and in vitro drug dissolution. Optimized films were obtained from aqueous gels containing 2.5% w/w κ-carrageenanud911, 4% w/w poloxamer 407 and polyethylene glycol (PEG) 600 [5.5% w/w (non-drug loaded) and 6.5% w/wud(drug loaded)]. A maximum of 0.8% w/w ibuprofen could be incorporated into the gels to obtain films with optimumudcharacteristics. Texture analysis confirmed that optimum film flexibility was achieved from 5.5% w/w and 6.5% (w/w)udof PEG 600 for blank films and ibuprofen loaded films respectively. TGA showed residual water content of the films asudapproximately 5%. DSC revealed a Tg for ibuprofen at −53.87°C, a unified Tm for PEG 600/poloxamer mixture atud32.74°C and the existence of ibuprofen in amorphous form, and confirmed by XRPD. Drug dissolution at a pH simulatingudthat of saliva showed that amorphous ibuprofen was released from the films at a faster rate than the pure crystallineuddrug. The results show successful design of a carrageenan and poloxamer based drug delivery system with potential forudbuccal drug delivery and showed the conversion of crystalline ibuprofen to the amorphous form during film formation.
机译:溶剂型流延膜用作口腔粘膜,具有粘附在粘膜表面,水合并通过颊膜传递药物的潜力。这项研究的目的是开发具有最佳载药量的颊黏膜生物胶粘膜制剂。将由κ-角叉菜胶,泊洛沙姆和聚乙二醇或二甘油制得的膜装载布洛芬作为模型水不溶性药物。使用质地 udanalysis(TA),热台显微镜(HSM),差示扫描量热法(DSC),热重分析(TGA), udscan电子显微镜(SEM),x射线粉末衍射(XRPD),高高效液相色谱法(ud)(HPLC)和体外药物溶解。从含有2.5%w / wκ-卡拉胶 ud911、4%w / w泊洛沙姆407和聚乙二醇(PEG)600 [5.5%w / w(无药物)和6.5%w / w w ud(已加载药物)]。最多可将0.8%w / w的布洛芬掺入凝胶中,以获得具有最佳 udcharacteristics的薄膜。质地分析证实,对于空白膜和布洛芬载剂膜,分别从PEG 600的5.5%w / w和6.5%(w / w) udof PEG 600可获得最佳的膜柔韧性。 TGA显示膜的残余水含量为约5%。 DSC显示在-53.87℃下布洛芬的Tg,在 ud32.74℃下PEG 600 /泊洛沙姆混合物的统一Tm和无定形形式的布洛芬的存在,并通过XRPD证实。在类似于唾液的pH值下药物溶解表明,无定形布洛芬以比纯结晶药物更快的速率从薄膜中释放出来。结果表明,成功设计了基于角叉菜胶和泊洛沙姆的药物递送系统,并具有潜在的 udbuccal药物递送功能,并显示了成膜过程中结晶布洛芬向无定形形式的转化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号